Covid-19 Innovation Challenges by Innoget

Fooling the Virus: A Fusion Protein as Virus-Specific Therapeutic

Posted by Covid-19 Innovation Challenges by InnogetVery responsive · Innovative Products and Technologies · United Kingdom

Summary of the technology

Fooling the Virus: The Fusion protein as Virus-Specific Therapeutic
An ACE2 A fusion protein of ACE2 with an Immunogenic Component
Project ID : 47-2020-10877

Covid-19 Innovation Challenges by Innoget

Description of the technology

  • Our laboratory has previously generated fusion proteins of a wide range of viral entry receptors. Among these is ACE2, a membrane-bound enzyme which also serves as the entry receptor for the SARS virus. Study of the novel coronavirus discovered in Wuhan, China has shown striking similarities to the known strains of SARS. This includes work which has suggested that the two viruses share an entry receptor, namely ACE2.
  • Given the immense burden of the novel coronavirus due to its public health threat, development of therapies is critical, we propose use of our fusion protein, which can serve as a decoy receptor for the virus. Attachment of the fusion protein will not only limit its entry into host cells – thereby hampering spread of disease, and acting as a complement-inducing opsinogen for direct viral lysis.
  • We therefore suggest that our fusion protein is not only a useful research tool for studying this deadly virus, but may also hold promise as a virus-specific therapeutic

Project manager

Keren-Or Amar
VP, Business Development, Healthcare

Project researchers

Ofer Mandelboim
HUJI, School of Medicine - IMRIC
Immunology and Cancer Research

Technology Owner

Covid-19 Innovation Challenges by Innoget

Innovation Intermediary

Related keywords

  • Biological Sciences
  • Virus, Virology / Antibiotics / Bacteriology
  • Biology / Biotechnology
  • Genetic Engineering Technology
  • Genetic Engineering / Molecular Biology
  • Covid-19

About Covid-19 Innovation Challenges by Innoget

Innovation Intermediary from United Kingdom

Ahead of the current Coronavirus outbreak, Innoget is fully committed to contributing to mobilizing scientific and expert communities to find a real solution to the Covid-19 pandemic. Therefore, we're supporting worldwide calls and programs that could help in any aspects of the coronavirus crisis.

Is your organization promoting or looking for innovation or research initiatives to mitigate the Covid-19 outbreak? Email us at covid19@innoget.com to list them.

Channeled through Innoget's online open innovation network, initiatives in the health, virology, medicine, or novel technologies applied to human health, among others, are listed and disseminated to Innoget members -ranging from hospitals, research institutes, scientists, businesses, and public administrations- and innovation partners worldwide.

Technology Offers on Innoget are directly posted and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.